Experimental and Clinical Basis for the Use of Statins in Patients With Ischemic and Nonischemic Cardiomyopathy
- 1 January 2008
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 51 (4) , 415-426
- https://doi.org/10.1016/j.jacc.2007.10.009
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- The Rac and Rho Hall of FameCirculation Research, 2006
- Neutral Effect on Markers of Heart Failure, Inflammation, Endothelial Activation and Function, and Vagal Tone After High-Dose HMG-CoA Reductase Inhibition in Non-Diabetic Patients With Non-Ischemic Cardiomyopathy and Average Low-Density Lipoprotein LevelJournal of the American College of Cardiology, 2005
- Isoprenoid metabolism and the pleiotropic effects of statinsCurrent Atherosclerosis Reports, 2003
- Regulation of cytokine signaling and inflammationCytokine & Growth Factor Reviews, 2002
- Isoprenoids as mediators of the biological effects of statinsJournal of Clinical Investigation, 2002
- Impact of HMG CoA reductase inhibition on small GTPases in the heartCardiovascular Research, 2002
- Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1Journal of Biological Chemistry, 1999
- Interleukin-1 in Myocardium and Coronary Arteries of Patients with Dilated CardiomyopathyJournal of Molecular and Cellular Cardiology, 1998
- Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)Journal of the American College of Cardiology, 1996
- Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart FailureNew England Journal of Medicine, 1990